{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:20:52Z","timestamp":1757611252949,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82400734","No. 82302539","No. 82170640"],"award-info":[{"award-number":["No. 82400734","No. 82302539","No. 82170640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No.2023JJ40998","No. 2023JJ40929"],"award-info":[{"award-number":["No.2023JJ40998","No. 2023JJ40929"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Changsha City Natural Science Foundation","award":["No. kq2208371","No. kq2208401"],"award-info":[{"award-number":["No. kq2208371","No. kq2208401"]}]},{"name":"Fundamental Research Funds for the Central South University","award":["No.2022ZZTS0820"],"award-info":[{"award-number":["No.2022ZZTS0820"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00335-025-10146-8","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T15:15:10Z","timestamp":1750086910000},"page":"928-938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive identification of crucial biomarkers and therapeutic targets in cholestasis via integrated single-cell RNA and transcriptome sequencing analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Cichun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nianqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shifang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"10146_CR1","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","volume":"69","author":"GA Baselli","year":"2020","unstructured":"Baselli GA, Dongiovanni P, Rametta R, Meroni M, Pelusi S, Maggioni M, Badiali S, Pingitore P, Maurotti S, Montalcini T, Taliento AE, Prati D, Rossi G, Fracanzani AL, Mancina RM, Romeo S, Valenti L (2020) Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut 69:1855\u20131866. https:\/\/doi.org\/10.1136\/gutjnl-2019-319226","journal-title":"Gut"},{"key":"10146_CR2","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jhep.2023.03.031","volume":"79","author":"F Bolduan","year":"2023","unstructured":"Bolduan F, Geisel D, Pahl S, Wree A, Tacke F (2023) Painless jaundice with segmental obstructive cholestasis. J Hepatol 79:e16\u2013e18. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.031","journal-title":"J Hepatol"},{"key":"10146_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/v15030700","author":"R Bunet","year":"2023","unstructured":"Bunet R, Roy-Cardinal MH, Ramani H, Cleret-Buhot A, Durand M, Chartrand-Lefebvre C, Routy JP, Thomas R, Trottier B, Ancuta P, Hanna DB, Landay AL, Cloutier G, Tremblay CL, El-Far M (2023) Differential impact of IL-32 isoforms on the functions of coronary artery endothelial cells: a potential link with arterial stiffness and atherosclerosis. Viruses. https:\/\/doi.org\/10.3390\/v15030700","journal-title":"Viruses"},{"key":"10146_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/liv.14260","volume":"40","author":"C Corpechot","year":"2020","unstructured":"Corpechot C, Barbu V, Chazouilleres O, Broue P, Girard M, Roquelaure B, Chretien Y, Dong C, Lascols O, Housset C, Jeru I (2020) Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders. Liver International: Official J Int Association Study Liver 40:163\u2013174. https:\/\/doi.org\/10.1111\/liv.14260","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"10146_CR5","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/hep4.2103","volume":"6","author":"D Ding","year":"2022","unstructured":"Ding D, Guo G, Liu Y, Zheng L, Jia G, Deng J, Sun R, Wang X, Guo C, Shang Y, Han Y (2022) Efficacy and safety of Fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid. Hepatol Commun 6:3487\u20133495. https:\/\/doi.org\/10.1002\/hep4.2103","journal-title":"Hepatol Commun"},{"key":"10146_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/hep.31087","volume":"71","author":"E Gao","year":"2020","unstructured":"Gao E, Cheema H, Waheed N, Mushtaq I, Erden N, Nelson-Williams C, Jain D, Soroka CJ, Boyer JL, Khalil Y, Clayton PT, Mistry PK, Lifton RP, Vilarinho S (2020) Organic solute transporter alpha deficiency: A disorder with cholestasis, liver fibrosis, and congenital diarrhea. Hepatology 71:1879\u20131882. https:\/\/doi.org\/10.1002\/hep.31087","journal-title":"Hepatology"},{"key":"10146_CR7","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/liv.13880","volume":"38","author":"J Goldstein","year":"2018","unstructured":"Goldstein J, Levy C (2018) Novel and emerging therapies for cholestatic liver diseases. Liver International: Official J Int Association Study Liver 38:1520\u20131535. https:\/\/doi.org\/10.1111\/liv.13880","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"10146_CR8","doi-asserted-by":"publisher","first-page":"1083780","DOI":"10.3389\/fimmu.2022.1083780","volume":"13","author":"J Gong","year":"2022","unstructured":"Gong J, Tu W, Liu J, Tian D (2022) Hepatocytes: A key role in liver inflammation. Front Immunol 13:1083780. https:\/\/doi.org\/10.3389\/fimmu.2022.1083780","journal-title":"Front Immunol"},{"key":"10146_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.mayocp.2020.01.015","volume":"95","author":"MB Hilscher","year":"2020","unstructured":"Hilscher MB, Kamath PS, Eaton JE (2020) Cholestatic liver diseases: A primer for generalists and subspecialists. Mayo Clin Proc 95:2263\u20132279. https:\/\/doi.org\/10.1016\/j.mayocp.2020.01.015","journal-title":"Mayo Clin Proc"},{"key":"10146_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000496","author":"BD Juran","year":"2024","unstructured":"Juran BD, McCauley BM, Atkinson EJ, Schlicht EM, Bianchi JK, Vollenweider JM, Ye H, LaRusso NF, Gores GJ, Sun Z, Lazaridis KN (2024) Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease. Hepatol Commun. https:\/\/doi.org\/10.1097\/HC9.0000000000000496","journal-title":"Hepatol Commun"},{"key":"10146_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.14218\/JCTH.2022.00147","volume":"10","author":"L Lu","year":"2022","unstructured":"Lu L, Chinese Society of H, Chinese Medical A (2022) Guidelines for the management of cholestatic liver diseases (2021). J Clin Translational Hepatol 10:757\u2013769. https:\/\/doi.org\/10.14218\/JCTH.2022.00147","journal-title":"J Clin Translational Hepatol"},{"key":"10146_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.4103\/sjg.sjg_112_21","volume":"27","author":"M Mawardi","year":"2021","unstructured":"Mawardi M, Alalwan A, Fallatah H, Abaalkhail F, Hasosah M, Shagrani M, Alghamdi MY, Alghamdi AS (2021) Cholestatic liver disease: practice guidelines from the Saudi association for the study of liver diseases and transplantation. Saudi J Gastroenterol 27:S1\u2013s26. https:\/\/doi.org\/10.4103\/sjg.sjg_112_21","journal-title":"Saudi J Gastroenterol"},{"key":"10146_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D, Group PS (2016) A Placebo-Controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 375:631\u2013643. https:\/\/doi.org\/10.1056\/NEJMoa1509840","journal-title":"N Engl J Med"},{"key":"10146_CR14","doi-asserted-by":"publisher","first-page":"102860","DOI":"10.1016\/j.jaut.2022.102860","volume":"131","author":"W Ning","year":"2022","unstructured":"Ning W, Cheng D, Howe PH, Bian C, Kamen DL, Luo Z, Fu X, Ogunrinde E, Yang L, Wang X, Li QZ, Oates J, Zhang W, White D, Wan Z, Gilkeson GS, Jiang W (2022) Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun 131:102860. https:\/\/doi.org\/10.1016\/j.jaut.2022.102860","journal-title":"J Autoimmun"},{"key":"10146_CR15","doi-asserted-by":"publisher","first-page":"152968","DOI":"10.1016\/j.tox.2021.152968","volume":"463","author":"LG Poole","year":"2021","unstructured":"Poole LG, Fournier AK, Cline-Fedewa HM, Kopec AK, Luyendyk JP, Groeneveld DJ (2021) Von Willebrand factor exerts hepatoprotective effects in acute but not chronic cholestatic liver injury in mice. Toxicology 463:152968. https:\/\/doi.org\/10.1016\/j.tox.2021.152968","journal-title":"Toxicology"},{"key":"10146_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.34172\/mejdd.2023.336","volume":"15","author":"SS Rini","year":"2023","unstructured":"Rini SS, Wibawa IDN (2023) Evaluation and management of chronic cholestatic liver diseases. Middle East J Dig Dis 15:148\u2013155. https:\/\/doi.org\/10.34172\/mejdd.2023.336","journal-title":"Middle East J Dig Dis"},{"key":"10146_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081623","author":"M Roginskaya","year":"2023","unstructured":"Roginskaya M, Razskazovskiy Y (2023) Oxidative DNA damage and repair: mechanisms, mutations, and relation to diseases. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox12081623","journal-title":"Antioxidants (Basel)"},{"key":"10146_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081604","author":"DS Semenovich","year":"2023","unstructured":"Semenovich DS, Andrianova NV, Zorova LD, Pevzner IB, Abramicheva PA, Elchaninov AV, Markova OV, Petrukhina AS, Zorov DB, Plotnikov EY (2023) Fibrosis development linked to alterations in glucose and energy metabolism and prooxidant-antioxidant balance in experimental models of liver injury. Antioxid (Basel). https:\/\/doi.org\/10.3390\/antiox12081604","journal-title":"Antioxid (Basel)"},{"key":"10146_CR19","first-page":"3816","volume":"11","author":"W Wang","year":"2019","unstructured":"Wang W, Xiao Y, Li S, Zhu X, Meng L, Song C, Yu C, Jiang N, Liu Y (2019) Synergistic activity of Magnolin combined with B-RAF inhibitor SB590885 in hepatocellular carcinoma cells via targeting PI3K-AKT\/mTOR and ERK MAPK pathway. Am J Transl Res 11:3816\u20133824","journal-title":"Am J Transl Res"},{"key":"10146_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12072-023-10622-w","volume":"18","author":"H Wu","year":"2024","unstructured":"Wu H, Zhou M, Jin Q, Wang X, Xu Y, Li M, Chen S, Tang Q, Wang Q, Hu B, Wu H, Xiao M, Qu L, Zhang Q, Liu J (2024) The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK\/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease. Hepatol Int 18:1144\u20131157. https:\/\/doi.org\/10.1007\/s12072-023-10622-w","journal-title":"Hepatol Int"},{"key":"10146_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","volume":"12","author":"RT Yokoda","year":"2020","unstructured":"Yokoda RT, Rodriguez EA (2020) Review: pathogenesis of cholestatic liver diseases. World J Hepatol 12:423\u2013435. https:\/\/doi.org\/10.4254\/wjh.v12.i8.423","journal-title":"World J Hepatol"},{"key":"10146_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/HEP.0000000000000317","volume":"78","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lyu Z, Li B, You Z, Cui N, Li Y, Li Y, Huang B, Chen R, Chen Y, Peng Y, Fang J, Wang Q, Miao Q, Tang R, Gershwin ME, Lian M, Xiao X, Ma X (2023) P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology 78:10\u201325. https:\/\/doi.org\/10.1097\/HEP.0000000000000317","journal-title":"Hepatology"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-025-10146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-025-10146-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-025-10146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:36:08Z","timestamp":1756924568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-025-10146-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10146"],"URL":"https:\/\/doi.org\/10.1007\/s00335-025-10146-8","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"type":"print","value":"0938-8990"},{"type":"electronic","value":"1432-1777"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local institutional review board [IRB(S) No. 202212311] with informed consent obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}